Propofol anaesthesia in mice is potentiated by muscimol and reversed by bicuculline

M Irifune1, M Sugimura, T Takarada

  • 1Department of Anaesthesiology, Hiroshima University School of Dentistry, Japan.

Insights

Propofol anesthesia

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • General anesthesia involves complex neurobiological mechanisms.
  • Gamma-aminobutyric acid (GABA) is a key inhibitory neurotransmitter in the central nervous system.

Purpose of the Study:

  • To investigate the role of GABA neurons in propofol-induced anesthesia in a mouse model.
  • To determine if GABAergic pathways mediate the anesthetic effects of propofol.

Main Methods:

  • The righting reflex in mice was used to assess anesthetic effects.
  • Dose-response curves were generated for propofol administration.
  • The effects of a GABA_A receptor agonist (muscimol) and antagonist (bicuculline) on propofol's ED50 were evaluated.

Main Results:

  • Propofol induced a dose-dependent loss of the righting reflex (ED50 = 140 mg/kg).
  • The ED50 of propofol was significantly reduced by the GABA_A agonist muscimol (ED50 = 66 mg/kg).
  • The GABA_A antagonist bicuculline significantly increased the ED50 of propofol (ED50 = 240 mg/kg).

Conclusions:

  • These findings suggest that GABA neurons play a significant role in mediating propofol anesthesia.
  • Propofol's anesthetic effects appear to be, at least partially, dependent on the GABAergic system.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...